Exit Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$271K Buy
1,036
+2
+0.2% +$513 0.12% 122
2026
Q2
$260K Buy
+1,034
New +$222K 0.12% 130

Other funds holding ABBV

Exit Wealth Advisors's ABBV Position: Q3 2026 in Review

Exit Wealth Advisors increased its AbbVie (ABBV) stake by 0.19% in Q3 2026, buying an estimated $513 and bringing the position to 1,036 shares worth $271K. The position accounts for 0.12% of the portfolio, ranked #122.

Exit Wealth Advisors first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Exit Wealth Advisors held 1,036 shares of AbbVie worth $271K as of Q3 2026.
  • Exit Wealth Advisors bought 2 AbbVie shares in Q3 2026, an estimated $513.
  • AbbVie made up 0.12% of Exit Wealth Advisors's portfolio in Q3 2026, its #122 holding.
  • Exit Wealth Advisors first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Exit Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.